melatonin has been researched along with Lymphoma, Non-Hodgkin in 2 studies
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sánchez-Hidalgo, M | 1 |
| Lee, M | 1 |
| de la Lastra, CA | 1 |
| Guerrero, JM | 1 |
| Packham, G | 1 |
| Todisco, M | 1 |
| Casaccia, P | 1 |
| Rossi, N | 1 |
1 trial available for melatonin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antioxidan | 2001 |
1 other study available for melatonin and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Proliferation; Dose-Respons | 2012 |